203922-16-1Relevant articles and documents
PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES
-
Paragraph 0051, (2014/09/29)
Provided is a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof. This novel compound has a glycogen-synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. In th
A practical approach to highly functionalized benzodihydrofurans
Plotkin, Michael,Chen, Sanyou,Spoors, P. Grant
, p. 2269 - 2273 (2007/10/03)
A number of aromatic dibromides have been treated with 2-3 equivalents of n-butyllithium in order to initiate two sequential chemical events, a Parham cyclization and an intermolecular reaction with DMF. (C) 2000 Elsevier Science Ltd.
4-AMINOETHOXY INDOLONE DERIVATIVES
-
, (2008/06/13)
A compound of the formula I: STR1 in which Y is hydrogen, halogen or lower alkoxy; R 1 is hydrogen, lower alkyl or aryl(lower) alkyl; R. sub.2 is hydrogen, lower alkyl or--(CH 2) n X p Ar, where X is oxygen or carbonyl; Ar is cycloalkyl, aryl or arylaryl, oxindolyl, benzimidazolyl, indolyl, 2-oxobenzimidazolyl or 2-thioxobenzimidazolyl; or R 1 and R 2, taken together with the nitrogen atom to which they are attached, complete a 3,4-dihydro-1H-isoquinolinyl or 1,3-dihydro-isoindolyl; n is one of the integers 1,2,3, 4,5 or 6; p is one of the integers 0 or 1; or a pharmaceutically acceptable salt thereof are inhibitors of dopamine synthesis and release, useful in the treatment of schizophrenia, Parkinson's Disease, Tourette's Syndrome, alcohol addiction, cocaine addiction, and addiction to analogous drugs.